Clinical Trials Directory

Trials / Completed

CompletedNCT01447095

Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage

Effect of Prostacyclin Infusion on Cerebral Vessels, Cerebral Bloodflow and Cerebral Metabolism in Patients With Subarachnoid Haemorrhage

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Rune Rasmussen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether prostacyclin is effective in prevention of cerebral vasospasm in patients with subarachnoidal hemorrhage (SAH).

Conditions

Interventions

TypeNameDescription
DRUGProstacyclin 1 ng/kg/minContinuous i.v. infusion of epoprostenol 1 ng/kg/min day 5-10 after SAH
DRUGProstacyclin 2 ng/kg/minContinuous i.v. infusion of epoprostenol 2 ng/kg/min day 5-10 after SAH
DRUGPlaceboContinuous i.v. infusion with placebo day 5-10 after SAH

Timeline

Start date
2011-10-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2011-10-05
Last updated
2014-07-21

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01447095. Inclusion in this directory is not an endorsement.

Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage (NCT01447095) · Clinical Trials Directory